The global market for Nanomedicines was valued at US$ 180 million in the year 2024 and is projected to reach a revised size of US$ 276 million by 2031, growing at a CAGR of 6.4% during the forecast period.

Nanomedicines Market

Nanotechnology refers to the engineering of functional systems at the molecular scale. It includes construction of items from the bottom up, using modern techniques and tools to make complete, high-performance products. Nanomedicines refer to medications that are based on the application of nanotechnology in the medical field. They include monitoring, construction, repair, and control of human biological systems at the molecular level, using nanodevices and nanostructures.

Factors such as aging populations, increasing prevalence of disorders that could be treated better with nanomedicines, and growing awareness about the availability of alternative treatment using nanomedicines are driving the global nanomedicines market.

This report aims to provide a comprehensive presentation of the global market for Nanomedicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanomedicines.

The Nanomedicines market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nanomedicines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nanomedicines companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Nanomedicines Market Report

Report Metric	Details
Report Name	Nanomedicines Market
Accounted market size in year	US$ 180 million
Forecasted market size in 2031	US$ 276 million
CAGR	6.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Nanoparticles Nanoshells Nanotubes Nanodevices Others
Segment by Application	Hospitals Clinics Research Institute
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott, GE Healthcare, Johnson & Johnson, Merck, Pfizer, CombiMatrix, Celgene, Mallinckrodt, Sigma-Tau Pharmaceuticals, Teva Pharmaceutical, Nanosphere, UCB SA
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nanomedicines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Nanomedicines Market growing?

Ans: The Nanomedicines Market witnessing a CAGR of 6.4% during the forecast period 2025-2031.

What is the Nanomedicines Market size in 2031?

Ans: The Nanomedicines Market size in 2031 will be US$ 276 million.

Who are the main players in the Nanomedicines Market report?

Ans: The main players in the Nanomedicines Market are Abbott, GE Healthcare, Johnson & Johnson, Merck, Pfizer, CombiMatrix, Celgene, Mallinckrodt, Sigma-Tau Pharmaceuticals, Teva Pharmaceutical, Nanosphere, UCB SA

What are the Application segmentation covered in the Nanomedicines Market report?

Ans: The Applications covered in the Nanomedicines Market report are Hospitals, Clinics, Research Institute

What are the Type segmentation covered in the Nanomedicines Market report?

Ans: The Types covered in the Nanomedicines Market report are Nanoparticles, Nanoshells, Nanotubes, Nanodevices, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Nanomedicines Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Nanoparticles

1.2.3 Nanoshells

1.2.4 Nanotubes

1.2.5 Nanodevices

1.2.6 Others

1.3 Market by Application

1.3.1 Global Nanomedicines Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Research Institute

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Nanomedicines Market Perspective (2020-2031)

2.2 Global Nanomedicines Growth Trends by Region

2.2.1 Global Nanomedicines Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Nanomedicines Historic Market Size by Region (2020-2025)

2.2.3 Nanomedicines Forecasted Market Size by Region (2026-2031)

2.3 Nanomedicines Market Dynamics

2.3.1 Nanomedicines Industry Trends

2.3.2 Nanomedicines Market Drivers

2.3.3 Nanomedicines Market Challenges

2.3.4 Nanomedicines Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Nanomedicines Players by Revenue

3.1.1 Global Top Nanomedicines Players by Revenue (2020-2025)

3.1.2 Global Nanomedicines Revenue Market Share by Players (2020-2025)

3.2 Global Nanomedicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Nanomedicines Revenue

3.4 Global Nanomedicines Market Concentration Ratio

3.4.1 Global Nanomedicines Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Nanomedicines Revenue in 2024

3.5 Global Key Players of Nanomedicines Head office and Area Served

3.6 Global Key Players of Nanomedicines, Product and Application

3.7 Global Key Players of Nanomedicines, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Nanomedicines Breakdown Data by Type

4.1 Global Nanomedicines Historic Market Size by Type (2020-2025)

4.2 Global Nanomedicines Forecasted Market Size by Type (2026-2031)

5 Nanomedicines Breakdown Data by Application

5.1 Global Nanomedicines Historic Market Size by Application (2020-2025)

5.2 Global Nanomedicines Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Nanomedicines Market Size (2020-2031)

6.2 North America Nanomedicines Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Nanomedicines Market Size by Country (2020-2025)

6.4 North America Nanomedicines Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Nanomedicines Market Size (2020-2031)

7.2 Europe Nanomedicines Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Nanomedicines Market Size by Country (2020-2025)

7.4 Europe Nanomedicines Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Nanomedicines Market Size (2020-2031)

8.2 Asia-Pacific Nanomedicines Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Nanomedicines Market Size by Region (2020-2025)

8.4 Asia-Pacific Nanomedicines Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Nanomedicines Market Size (2020-2031)

9.2 Latin America Nanomedicines Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Nanomedicines Market Size by Country (2020-2025)

9.4 Latin America Nanomedicines Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Nanomedicines Market Size (2020-2031)

10.2 Middle East & Africa Nanomedicines Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Nanomedicines Market Size by Country (2020-2025)

10.4 Middle East & Africa Nanomedicines Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott

11.1.1 Abbott Company Details

11.1.2 Abbott Business Overview

11.1.3 Abbott Nanomedicines Introduction

11.1.4 Abbott Revenue in Nanomedicines Business (2020-2025)

11.1.5 Abbott Recent Development

11.2 GE Healthcare

11.2.1 GE Healthcare Company Details

11.2.2 GE Healthcare Business Overview

11.2.3 GE Healthcare Nanomedicines Introduction

11.2.4 GE Healthcare Revenue in Nanomedicines Business (2020-2025)

11.2.5 GE Healthcare Recent Development

11.3 Johnson & Johnson

11.3.1 Johnson & Johnson Company Details

11.3.2 Johnson & Johnson Business Overview

11.3.3 Johnson & Johnson Nanomedicines Introduction

11.3.4 Johnson & Johnson Revenue in Nanomedicines Business (2020-2025)

11.3.5 Johnson & Johnson Recent Development

11.4 Merck

11.4.1 Merck Company Details

11.4.2 Merck Business Overview

11.4.3 Merck Nanomedicines Introduction

11.4.4 Merck Revenue in Nanomedicines Business (2020-2025)

11.4.5 Merck Recent Development

11.5 Pfizer

11.5.1 Pfizer Company Details

11.5.2 Pfizer Business Overview

11.5.3 Pfizer Nanomedicines Introduction

11.5.4 Pfizer Revenue in Nanomedicines Business (2020-2025)

11.5.5 Pfizer Recent Development

11.6 CombiMatrix

11.6.1 CombiMatrix Company Details

11.6.2 CombiMatrix Business Overview

11.6.3 CombiMatrix Nanomedicines Introduction

11.6.4 CombiMatrix Revenue in Nanomedicines Business (2020-2025)

11.6.5 CombiMatrix Recent Development

11.7 Celgene

11.7.1 Celgene Company Details

11.7.2 Celgene Business Overview

11.7.3 Celgene Nanomedicines Introduction

11.7.4 Celgene Revenue in Nanomedicines Business (2020-2025)

11.7.5 Celgene Recent Development

11.8 Mallinckrodt

11.8.1 Mallinckrodt Company Details

11.8.2 Mallinckrodt Business Overview

11.8.3 Mallinckrodt Nanomedicines Introduction

11.8.4 Mallinckrodt Revenue in Nanomedicines Business (2020-2025)

11.8.5 Mallinckrodt Recent Development

11.9 Sigma-Tau Pharmaceuticals

11.9.1 Sigma-Tau Pharmaceuticals Company Details

11.9.2 Sigma-Tau Pharmaceuticals Business Overview

11.9.3 Sigma-Tau Pharmaceuticals Nanomedicines Introduction

11.9.4 Sigma-Tau Pharmaceuticals Revenue in Nanomedicines Business (2020-2025)

11.9.5 Sigma-Tau Pharmaceuticals Recent Development

11.10 Teva Pharmaceutical

11.10.1 Teva Pharmaceutical Company Details

11.10.2 Teva Pharmaceutical Business Overview

11.10.3 Teva Pharmaceutical Nanomedicines Introduction

11.10.4 Teva Pharmaceutical Revenue in Nanomedicines Business (2020-2025)

11.10.5 Teva Pharmaceutical Recent Development

11.11 Nanosphere

11.11.1 Nanosphere Company Details

11.11.2 Nanosphere Business Overview

11.11.3 Nanosphere Nanomedicines Introduction

11.11.4 Nanosphere Revenue in Nanomedicines Business (2020-2025)

11.11.5 Nanosphere Recent Development

11.12 UCB SA

11.12.1 UCB SA Company Details

11.12.2 UCB SA Business Overview

11.12.3 UCB SA Nanomedicines Introduction

11.12.4 UCB SA Revenue in Nanomedicines Business (2020-2025)

11.12.5 UCB SA Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Sigma-Tau Pharmaceuticals

Teva Pharmaceutical

Nanosphere

UCB SA

List of Tables

Table 1. Global Nanomedicines Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Nanoparticles

Table 3. Key Players of Nanoshells

Table 4. Key Players of Nanotubes

Table 5. Key Players of Nanodevices

Table 6. Key Players of Others

Table 7. Global Nanomedicines Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Nanomedicines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Nanomedicines Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Nanomedicines Market Share by Region (2020-2025)

Table 11. Global Nanomedicines Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Nanomedicines Market Share by Region (2026-2031)

Table 13. Nanomedicines Market Trends

Table 14. Nanomedicines Market Drivers

Table 15. Nanomedicines Market Challenges

Table 16. Nanomedicines Market Restraints

Table 17. Global Nanomedicines Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Nanomedicines Market Share by Players (2020-2025)

Table 19. Global Top Nanomedicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanomedicines as of 2024)

Table 20. Ranking of Global Top Nanomedicines Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Nanomedicines Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Nanomedicines, Headquarters and Area Served

Table 23. Global Key Players of Nanomedicines, Product and Application

Table 24. Global Key Players of Nanomedicines, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Nanomedicines Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Nanomedicines Revenue Market Share by Type (2020-2025)

Table 28. Global Nanomedicines Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Nanomedicines Revenue Market Share by Type (2026-2031)

Table 30. Global Nanomedicines Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Nanomedicines Revenue Market Share by Application (2020-2025)

Table 32. Global Nanomedicines Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Nanomedicines Revenue Market Share by Application (2026-2031)

Table 34. North America Nanomedicines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Nanomedicines Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Nanomedicines Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Nanomedicines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Nanomedicines Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Nanomedicines Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Nanomedicines Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Nanomedicines Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Nanomedicines Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Nanomedicines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Nanomedicines Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Nanomedicines Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Nanomedicines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Nanomedicines Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Nanomedicines Market Size by Country (2026-2031) & (US$ Million)

Table 49. Abbott Company Details

Table 50. Abbott Business Overview

Table 51. Abbott Nanomedicines Product

Table 52. Abbott Revenue in Nanomedicines Business (2020-2025) & (US$ Million)

Table 53. Abbott Recent Development

Table 54. GE Healthcare Company Details

Table 55. GE Healthcare Business Overview

Table 56. GE Healthcare Nanomedicines Product

Table 57. GE Healthcare Revenue in Nanomedicines Business (2020-2025) & (US$ Million)

Table 58. GE Healthcare Recent Development

Table 59. Johnson & Johnson Company Details

Table 60. Johnson & Johnson Business Overview

Table 61. Johnson & Johnson Nanomedicines Product

Table 62. Johnson & Johnson Revenue in Nanomedicines Business (2020-2025) & (US$ Million)

Table 63. Johnson & Johnson Recent Development

Table 64. Merck Company Details

Table 65. Merck Business Overview

Table 66. Merck Nanomedicines Product

Table 67. Merck Revenue in Nanomedicines Business (2020-2025) & (US$ Million)

Table 68. Merck Recent Development

Table 69. Pfizer Company Details

Table 70. Pfizer Business Overview

Table 71. Pfizer Nanomedicines Product

Table 72. Pfizer Revenue in Nanomedicines Business (2020-2025) & (US$ Million)

Table 73. Pfizer Recent Development

Table 74. CombiMatrix Company Details

Table 75. CombiMatrix Business Overview

Table 76. CombiMatrix Nanomedicines Product

Table 77. CombiMatrix Revenue in Nanomedicines Business (2020-2025) & (US$ Million)

Table 78. CombiMatrix Recent Development

Table 79. Celgene Company Details

Table 80. Celgene Business Overview

Table 81. Celgene Nanomedicines Product

Table 82. Celgene Revenue in Nanomedicines Business (2020-2025) & (US$ Million)

Table 83. Celgene Recent Development

Table 84. Mallinckrodt Company Details

Table 85. Mallinckrodt Business Overview

Table 86. Mallinckrodt Nanomedicines Product

Table 87. Mallinckrodt Revenue in Nanomedicines Business (2020-2025) & (US$ Million)

Table 88. Mallinckrodt Recent Development

Table 89. Sigma-Tau Pharmaceuticals Company Details

Table 90. Sigma-Tau Pharmaceuticals Business Overview

Table 91. Sigma-Tau Pharmaceuticals Nanomedicines Product

Table 92. Sigma-Tau Pharmaceuticals Revenue in Nanomedicines Business (2020-2025) & (US$ Million)

Table 93. Sigma-Tau Pharmaceuticals Recent Development

Table 94. Teva Pharmaceutical Company Details

Table 95. Teva Pharmaceutical Business Overview

Table 96. Teva Pharmaceutical Nanomedicines Product

Table 97. Teva Pharmaceutical Revenue in Nanomedicines Business (2020-2025) & (US$ Million)

Table 98. Teva Pharmaceutical Recent Development

Table 99. Nanosphere Company Details

Table 100. Nanosphere Business Overview

Table 101. Nanosphere Nanomedicines Product

Table 102. Nanosphere Revenue in Nanomedicines Business (2020-2025) & (US$ Million)

Table 103. Nanosphere Recent Development

Table 104. UCB SA Company Details

Table 105. UCB SA Business Overview

Table 106. UCB SA Nanomedicines Product

Table 107. UCB SA Revenue in Nanomedicines Business (2020-2025) & (US$ Million)

Table 108. UCB SA Recent Development

Table 109. Research Programs/Design for This Report

Table 110. Key Data Information from Secondary Sources

Table 111. Key Data Information from Primary Sources

Table 112. Authors List of This Report

List of Figures

Figure 1. Nanomedicines Picture

Figure 2. Global Nanomedicines Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Nanomedicines Market Share by Type: 2024 VS 2031

Figure 4. Nanoparticles Features

Figure 5. Nanoshells Features

Figure 6. Nanotubes Features

Figure 7. Nanodevices Features

Figure 8. Others Features

Figure 9. Global Nanomedicines Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Nanomedicines Market Share by Application: 2024 VS 2031

Figure 11. Hospitals Case Studies

Figure 12. Clinics Case Studies

Figure 13. Research Institute Case Studies

Figure 14. Nanomedicines Report Years Considered

Figure 15. Global Nanomedicines Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Nanomedicines Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Nanomedicines Market Share by Region: 2024 VS 2031

Figure 18. Global Nanomedicines Market Share by Players in 2024

Figure 19. Global Top Nanomedicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanomedicines as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Nanomedicines Revenue in 2024

Figure 21. North America Nanomedicines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Nanomedicines Market Share by Country (2020-2031)

Figure 23. United States Nanomedicines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Nanomedicines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Nanomedicines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Nanomedicines Market Share by Country (2020-2031)

Figure 27. Germany Nanomedicines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Nanomedicines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Nanomedicines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Nanomedicines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Nanomedicines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Nanomedicines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Nanomedicines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Nanomedicines Market Share by Region (2020-2031)

Figure 35. China Nanomedicines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Nanomedicines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Nanomedicines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Nanomedicines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Nanomedicines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Nanomedicines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Nanomedicines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Nanomedicines Market Share by Country (2020-2031)

Figure 43. Mexico Nanomedicines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Nanomedicines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Nanomedicines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Nanomedicines Market Share by Country (2020-2031)

Figure 47. Turkey Nanomedicines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Nanomedicines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Nanomedicines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Abbott Revenue Growth Rate in Nanomedicines Business (2020-2025)

Figure 51. GE Healthcare Revenue Growth Rate in Nanomedicines Business (2020-2025)

Figure 52. Johnson & Johnson Revenue Growth Rate in Nanomedicines Business (2020-2025)

Figure 53. Merck Revenue Growth Rate in Nanomedicines Business (2020-2025)

Figure 54. Pfizer Revenue Growth Rate in Nanomedicines Business (2020-2025)

Figure 55. CombiMatrix Revenue Growth Rate in Nanomedicines Business (2020-2025)

Figure 56. Celgene Revenue Growth Rate in Nanomedicines Business (2020-2025)

Figure 57. Mallinckrodt Revenue Growth Rate in Nanomedicines Business (2020-2025)

Figure 58. Sigma-Tau Pharmaceuticals Revenue Growth Rate in Nanomedicines Business (2020-2025)

Figure 59. Teva Pharmaceutical Revenue Growth Rate in Nanomedicines Business (2020-2025)

Figure 60. Nanosphere Revenue Growth Rate in Nanomedicines Business (2020-2025)

Figure 61. UCB SA Revenue Growth Rate in Nanomedicines Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Nanotechnology for Healthcare Market Insights Forecast to 2030

Global Nanotechnology in Medical Market Insights Forecast to 2030

Global Nanotechnology based Drug Delivery Systems Market Research Report 2024

Nanotechnology in Medical Equipment Market

Nanotechnology in Healthcare Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Nano based Drug Delivery System Market Research Report 2024

Global Nano Medical Device Market Research Report 2025

Global Nanotechnology in Targeted Drug Delivery Market Research Report 2024

Global Nanomedicine Development and Manufacturing Services Market Research Report 2025

Nanomedicine and Nanobiotechnology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Nanotechnology Medical Devices Market Research Report 2025

Global Nanoparticle Mediated Delivery Market Research Report 2025

Global Nanopharmaceutical Drugs Market Insights Forecast to 2030

Medical Nanotechnology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Nanorobotics Market Insights Forecast to 2030

Global Nanopharmaceuticals Market Research Report 2025

Global Nanorobotics in Medicine Market Research Report 2025

Liposomes Nanoparticle Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Nanoparticle Drug Delivery System Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions